Unmasking New Solutions for OSA

By : Krishna Anindyo | Wednesday, May 20 2020 - 16:43 IWST

Danny Eckert sleep lab
Danny Eckert sleep lab

INDUSTRY co.idOSA, or repetitive upper airway closure during sleep that restricts breathing and is usually accompanied by snoring, has major adverse health, safety and economic impact. Even with established interventions such as continuous positive airway pressure (CPAP), these problems might not resolve.

 

Nearly 1 billion people globally, including 1 million Australians, have obstructive sleep apnoea (OSA) and more targeted treatments are ‘urgently needed’ to reduce the costs and health impacts, say Flinders University experts.

To find better, more effective, individually targeted treatments for people with OSA, Australian Federal Government funding of more than $2 million has been awarded to Flinders University’s Adelaide Institute for Sleep Health.

National Health and Medical Research Council Investigator Leadership grant awardee and Adelaide Institute for Sleep Health Director, Professor Danny Eckert, says a range of issues means OSA is often untreated, and more than 50% of people cannot tolerate long-term use of the main treatment, CPAP.

 

In all, sleep disorders and inadequate sleep cost Australia more than $65 billion per year, and sleep apnoea is the most common, says Matthew Flinders Fellow Professor Eckert.

&ldquo New treatments are urgently needed, and we’re aiming to use and develop novel approaches to identify the causes of OSA on a per patient basis, improve current therapies and management approaches and test if new targeted therapies can be used to treat OSA,” he says. Wednesday (5/20/2020).

“Current diagnosis, treatment and management of OSA are imprecise, are cumbersome, time-consuming, costly and are failing too often because they don’t take into account the differences in the ways people get OSA and the different ways it can present.”

Professor Eckert says his long-running research work takes a four-pronged approach to achieve much-needed improvement in this area of medicine, to Understand the different underlying causes of OSA to identify targets for therapy for each patient, Develop simplified yet more informative clinical tools to fast-track the diagnosis process and inform suitable, targeted treatment solutions for individual patients, Improve existing non-CPAP treatments such as dental devices and develop new drug interventions, Test the efficiency of new therapies, including combination therapies, to treat OSA.

OSA is the most common breathing related sleep disorder, restricting breathing to cause low oxygen levels (hypoxemia) and sleep disruption.

Untreated OSA increases the risk for heart disease and metabolic disorders such as diabetes, impaired cognitive function, cancer, depression, sleepiness, motor vehicle accidents and injury, and all-cause mortality.

News Comment

Today's Industry

GoTo is a blend of Gojek and Tokopedia. (Photo: republika.co.id)

Jumat, 02 Desember 2022 - 22:48 WIB

Lockup Sentiment Only Temporarily, GOTO Owns Chance to Rebound

Shares of PT Goto Gojek Tokopedia Tbk (GOTO), which experienced selling pressure after end of the lock up period on November 30, 2022, are considered by a number of market participants to provide…

GoTo is a blend of Gojek and Tokopedia. (Photo: republika.co.id)

Rabu, 30 November 2022 - 19:35 WIB

GoPay's Dominance Drives Consistency in GOTO's Financial Business Segment Growth

The financial services business segment, namely GoTo Financial owned by PT GoTo Gojek Tokopedia Tbk (GOTO), recorded impressive business growth consistency. This is reflected in GoPay's dominance…

The President Director of PT Honeywell Indonesia, Roy Kosashi, clarified many kind of leading technology for Indonesia’s New Capital City, in Jakarta on Tuesday (29/11/2022). (Photo: PT Honeywell Indonesia)

Rabu, 30 November 2022 - 19:28 WIB

Honeywell Ready to Support Indonesia’s New Capital City with Sustainability Technologies and Solutions

Honeywell announced today that it is Ready Now to support the Nusantara Capital Authority (OIKN) in realizing their goal of making a sustainable and smart forest city. OIKN is the government…

Gibu Mathew, Vice President and General Manager in Asia-Pacific (APAC) in Zoho Corp. (special)

Rabu, 30 November 2022 - 11:22 WIB

How to Make SaaS Work for Small and Medium-Sized Businesses

Southeast Asia's digital transformation has been impressive as the region is now poised to reach a projected digital economy worth USD360 billion by 2025. With digitalisation, the region bore…

PT Dharma Polimetal ("Dharma Group") Triputra Group automotive component manufacturing company.

Senin, 28 November 2022 - 12:15 WIB

DRMA Remains Optimistic 2023 Automotive Still Rises, Targets Sales Up 20%

PT Dharma Polimetal Tbk (“DRMA”), a listed company engaged in automotive component manufacturing business sees the prospects for the automotive business in 2023 will still remain promising.…